Form 4 for MET MetLife
Accepted 2026-06-03 16:07:36 ET · period of report 2026-06-01 · accession 0001770295-26-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-06-03 16:07 | 2026-06-01 | MET | DEBEL MARLENE | EVP, CRO | M - OptEx | $46.17 | +21.3K | 175.7K | +14% | +$984.0K |
| D | 2026-06-03 16:07 | 2026-06-01 | MET | DEBEL MARLENE | EVP, CRO | S - Sale+OE | $81.59 | -21.3K | 154.4K | -12% | -$1.74M |
| DM | 2026-06-03 16:07 | 2026-06-01 | MET | DEBEL MARLENE | EVP, CRO | M - OptEx | $0.00 | -21.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-01 | M | A | 10,600 | $46.85 | 164,980 | D | — | — | |
| 2 | Common | Common Stock | 2026-06-01 | M | A | 10,712 | $45.50 | 175,692 | D | — | — | |
| 3 | Common | Common Stock | 2026-06-01 | S | D | 21,312 | $81.59 | 154,380 | D | — | — | (F1) The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $81.57 to $81.65, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price. |
| 4 | Derivative | Employee Stock Options (right to buy) | 2026-06-01 | M | D | 10,600 | $0.00 | 0 | D | $46.85 · — to 2027-02-27 | 10,600 Common Stock | (F2) The options became exercisable in three substantially equal installments on February 28, 2018, 2019, and 2020. |
| 5 | Derivative | Employee Stock Options (right to buy) | 2026-06-01 | M | D | 10,712 | $0.00 | 0 | D | $45.50 · — to 2028-03-01 | 10,712 Common Stock | (F3) The options became exercisable in three substantially equal installments on March 2, 2019, 2020, and 2021. |